A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker

Yapeng Cao(First Affiliated Hospital of Xi'an Jiaotong University), Baochang Lai(Xi'an Jiaotong University), Liran Xu(Peking University), Haixia Duan(Northwest Women's and Children's Hospital), Ailing Su(First Affiliated Hospital of Xi'an Jiaotong University)
Aging
July 8, 2022
Cited by 14


Related Papers